These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 13186012)

  • 1. [Blood fibrinogen and fibrinolytic and fibrinogenolytic activity of plasma in Hodgkin's granuloma].
    ZARDI O
    Prog Med (Napoli); 1954 May; 10(10):294-7. PubMed ID: 13186012
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinogen in Hodgkin's disease].
    Hlousková D; Hermanská Z; Foltýnová V; Barták P; Maríková E
    Sb Lek; 1986 Jul; 88(7):199-202. PubMed ID: 3738409
    [No Abstract]   [Full Text] [Related]  

  • 3. [Hyperfibrinemia in Hodgkin's disease and in malignant reticular gangliopathies].
    CROIZAT P; REVOL L; BLANC R; BURLOUX G; BEL A
    Presse Med (1893); 1958 Sep; 66(66):1471. PubMed ID: 13601544
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hemostatic disorders in experimental leptospirosis in rabbits non-demonstrative of a common pathogenic cause of fibrinolytic and fibrinogenolytic action].
    ZARDI O
    Boll Soc Ital Biol Sper; 1954 Jul; 30(7):977-9. PubMed ID: 14351543
    [No Abstract]   [Full Text] [Related]  

  • 5. [Fibrinolytic and fibrinogenolytic activity as elements of diagnostic interest in the field of functional pathology of the liver; experimental research on rats treated with diet deficient in animal protein factor].
    ZARDI O; ROSSI M
    Rend Ist Sup Sanit; 1957; 20(2):207-10. PubMed ID: 13432224
    [No Abstract]   [Full Text] [Related]  

  • 6. The evaluation of fibrinogen behavior in Hodgkin's disease: correlation with clinical stage.
    Pengo V; Cartei G; Casara D; Daniele O; Fiorentino MV
    Tumori; 1983 Apr; 69(2):123-7. PubMed ID: 6679430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Blood fibrinogen level and fibrin and fibrinogenolytic phenomena in relation to blood coagulation in rabbits experimentally infected with leptospirosis].
    ZARDI O
    Rend Ist Sup Sanit; 1954; 17(11):1014-20. PubMed ID: 14385118
    [No Abstract]   [Full Text] [Related]  

  • 8. Duvernoy's gland secretion of Philodryas patagoniensis from the northeast of Argentina: its effects on blood coagulation.
    Peichoto ME; Leiva LC; Guaimás Moya LE; Rey L; Acosta O
    Toxicon; 2005 Mar; 45(4):527-34. PubMed ID: 15733575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Plasma insulin in Hodgkin's disease].
    Il'in NV; Korykova LI; Lapchenkov VI; Simbirtseva LP
    Med Radiol (Mosk); 1987 May; 32(5):79-80. PubMed ID: 3295456
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electrophoretic patterns of blood proteins in Hodgkin's disease].
    FIORILLO AM; JAMRA M
    Rev Assoc Med Bras; 1954 Jun; 1(2):176-8. PubMed ID: 13237517
    [No Abstract]   [Full Text] [Related]  

  • 11. [Studies on the influence of plasma in Hodgkin's disease on phytohemagglutinin transformation of normal lymphocytes].
    Pappas A; Scheurlen PG
    Verh Dtsch Ges Inn Med; 1968; 74():1254-6. PubMed ID: 5714289
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiogenic molecules in Hodgkin's disease: results from sequential serum analysis.
    Passam FH; Alexandrakis MG; Moschandrea J; Sfiridaki A; Roussou PA; Siafakas NM
    Int J Immunopathol Pharmacol; 2006; 19(1):161-70. PubMed ID: 16569354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Blood iron and blood copper in acute and chronic leukemia and in Hodgkin's disease].
    RECHENBERGER J
    Dtsch Z Verdau Stoffwechselkr; 1957 Apr; 17(2):78-85. PubMed ID: 13437842
    [No Abstract]   [Full Text] [Related]  

  • 14. [Action of Hodgkin's disease blood on normal cells cultured in vitro].
    DE LUSTIG ES; SACERDOTE F
    Publ B Aires Cent Investig; 1953; 17():67-75. PubMed ID: 13194801
    [No Abstract]   [Full Text] [Related]  

  • 15. [Nephrotic syndrome in Hodgkin's disease].
    Miltényi Z; Keresztes K; Ujhelyi L; Kovács J; Illés A
    Orv Hetil; 2005 Jun; 146(25):1357-60. PubMed ID: 16106759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Behavior of the C-reactive protein in malignant blood diseases, with special reference to Hodgkin's lymphogranuloma].
    PECORI V; TURRISI E; ALTUCCI P; BUONANNO G
    Riforma Med; 1959 Jan; 73(1):1-4. PubMed ID: 13634827
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
    Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
    J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Citric acid blood levels. II. Behavior in various malignant tumors, malignant blood diseases & Hodgkin's disease].
    RECHENBERGER J; BENNDORF S
    Z Klin Med; 1957; 154(6):660-8. PubMed ID: 13558353
    [No Abstract]   [Full Text] [Related]  

  • 19. [Contribution of immunoelectrophoresis to the study of malignant hemopathies (leukoses and Hodgkin's disease].
    GOUDEMAND M; FOUCAUT M
    Lille Med; 1960 Jun; 5():394-400. PubMed ID: 13707476
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiogenic and coagulation-fibrinolysis factors in non Hodgkin's lymphoma.
    Wróbel T; Poreba M; Mazur G; Poreba R; Pyszel A; Beck B; Steinmetz-Beck A; Andrzejak R; Kuliczkowski K
    Neoplasma; 2006; 53(3):253-8. PubMed ID: 16652197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.